BNP Paribas Aktienanleihe BAYN 27.../ DE000PE0B683 /
6/3/2024 4:20:54 PM | Chg.+0.780 | Bid4:40:32 PM | Ask4:40:32 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
48.720EUR | +1.63% | 48.490 Bid Size: 300,000 |
48.590 Ask Size: 300,000 |
BAYER AG NA O.N. | 60.00 - | 6/27/2024 | Call |
GlobeNewswire
4:00 PM
Revolutionary Baytec®SPR Membrane from Taiwan Hydroseal Demonstrates 20 Years of Excellence and Inno...
GlobeNewswire
8:30 AM
Orion is developing the Finnish life science industry in a unique collaboration project
GlobeNewswire
8:00 AM
FTI Consulting Adds Senior Chemicals Industry Expert to Further Expand Business Transformation Pract...
GlobeNewswire
5/30
Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
GlobeNewswire
5/30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
5/2
AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting...
GlobeNewswire
4/18
AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in conge...
GlobeNewswire
4/16
AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...
GlobeNewswire
4/11
Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from...
GlobeNewswire
3/25
BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rar...
GlobeNewswire
3/6
BlueRock Therapeutics phase I clinical trial for Parkinson’s disease continues to show positive tren...
GlobeNewswire
3/4
BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
GlobeNewswire
2/13
Corporate Alignment with Climate Goals Under Scrutiny: LyondellBasell & Bayer demonstrate good pract...